4//SEC Filing
Vance Terry 4
Accession 0001062993-23-022695
CIK 0001177648other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 8:08 PM ET
Size
4.9 KB
Accession
0001062993-23-022695
Insider Transaction Report
Form 4
Vance Terry
Director
Transactions
- Sale
Common Stock
2023-12-13$9.12/sh−15,295$139,490→ 5,800 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $8.80 to $9.56, inclusive. The reporting person undertakes to provide to Enanta Pharmaceuticals, Inc., any security holder of Enanta Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
Issuer
ENANTA PHARMACEUTICALS INC
CIK 0001177648
Entity typeother
Related Parties
1- filerCIK 0001572282
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 8:08 PM ET
- Size
- 4.9 KB